Health TrialsbyHealthPanel

The Workplace-Based Hypertension Management Program

ConditionHypertension
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorGuangxi Medical University

About this trial

This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18-60 years

Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria)

Employed in Kailuan Group workplace settings

Able to provide informed consent

Disqualifiers

Severe cardiovascular or renal disease at baseline

Psychiatric disorders affecting compliance

Pregnant or lactating women

Participation in other intervention trials

Trial design

Design model

Parallel

Treatments tested in this trial

  • Workplace-based Multicomponent Hypertension Management Program

    Behavioral

    Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.

  • Routine workplace health education and management according to current guidelines.

    Other intervention

    Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.

Treatment groups

512 Participants
are divided into 2 treatment groups
Group A: Standard Workplace Health ManagementActive comparator 1 intervention
Group B: Workplace-based Multicomponent Hypertension Management ProgramExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in systolic and diastolic blood pressure

Change in systolic and diastolic blood pressure from baseline to 12 months

Time frame
up to 12 months

Secondary outcomes

1

Changes in hypertension-related health behaviors

Changes in hypertension-related health behaviors (dietary intake, physical activity, medication adherence) at 12 months

Time frame
up to 12 months
2

Change in body mass index (BMI)

Change in body mass index (BMI) at 12 months

Time frame
up to 12 months
3

Work productivity and quality of life scores

Work productivity and quality of life scores (e.g., the European Quality of Life-5 Dimensions) at 12 months

Time frame
up to 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Guangxi Medical University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: